Blueberries Medical Corp.
BBM
CNSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -79.68% | 323.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -79.68% | 323.94% | |||
| Cost of Revenue | -82.23% | 1,331.52% | |||
| Gross Profit | -73.88% | 62.82% | |||
| SG&A Expenses | 209.35% | -6.09% | |||
| Depreciation & Amortization | -6.70% | -0.51% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 77.10% | 52.89% | |||
| Operating Income | -300.83% | 20.05% | |||
| Income Before Tax | -96.09% | -113.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -96.09% | -113.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -96.09% | -113.88% | |||
| EBIT | -300.83% | 20.05% | |||
| EBITDA | -353.84% | 22.77% | |||
| EPS Basic | -85.71% | -133.33% | |||
| Normalized Basic EPS | -300.00% | 0.00% | |||
| EPS Diluted | -85.71% | -133.33% | |||
| Normalized Diluted EPS | -300.00% | 0.00% | |||
| Average Basic Shares Outstanding | 1.60% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.60% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||